A group of international experts, including hematopathologists, oncologists, and geneticists were recently summoned (September 2021, Chicago, IL, USA) to update the 2016/17 World Health Organization classification system for hematopoietic tumors. After careful deliberation, the group introduced the new International Consensus Classification (ICC) for Myeloid Neoplasms and Acute Leukemias. This current in-depth review focuses on the ICC-2022 category of JAK2 mutation-prevalent myeloproliferative neoplasms (MPNs): essential thrombocythemia, polycythemia vera, primary myelofibrosis, and MPN, unclassifiable. The ICC MPN subcommittee chose to preserve the primary role of bone marrow morphology in disease classification and diagnostics, while also acknowledging the complementary role of genetic markers for establishing clonality, facilitating MPN subtype designation, and disease prognostication.

The international consensus classification of myeloid neoplasms and acute Leukemias: myeloproliferative neoplasms / J. Thiele, H. Kvasnicka, A. Orazi, U. Gianelli, N. Gangat, A. Vannucchi, T. Barbui, D. Arber, A. Tefferi. - In: AMERICAN JOURNAL OF HEMATOLOGY. - ISSN 0361-8609. - 98:1(2023 Jan), pp. 166-179. [10.1002/ajh.26751]

The international consensus classification of myeloid neoplasms and acute Leukemias: myeloproliferative neoplasms.

U. Gianelli
Membro del Collaboration Group
;
2023

Abstract

A group of international experts, including hematopathologists, oncologists, and geneticists were recently summoned (September 2021, Chicago, IL, USA) to update the 2016/17 World Health Organization classification system for hematopoietic tumors. After careful deliberation, the group introduced the new International Consensus Classification (ICC) for Myeloid Neoplasms and Acute Leukemias. This current in-depth review focuses on the ICC-2022 category of JAK2 mutation-prevalent myeloproliferative neoplasms (MPNs): essential thrombocythemia, polycythemia vera, primary myelofibrosis, and MPN, unclassifiable. The ICC MPN subcommittee chose to preserve the primary role of bone marrow morphology in disease classification and diagnostics, while also acknowledging the complementary role of genetic markers for establishing clonality, facilitating MPN subtype designation, and disease prognostication.
Settore MED/08 - Anatomia Patologica
gen-2023
Article (author)
File in questo prodotto:
File Dimensione Formato  
American J Hematol - 2022 - Thiele - The international consensus classification of myeloid neoplasms and acute Leukemias .pdf

accesso riservato

Descrizione: Critical Review
Tipologia: Publisher's version/PDF
Dimensione 2.03 MB
Formato Adobe PDF
2.03 MB Adobe PDF   Visualizza/Apri   Richiedi una copia
American J Hematol - 2023 - Thiele - The international consensus classification of myeloid neoplasms and acute leukemias .pdf

accesso riservato

Descrizione: Corrigendum
Tipologia: Post-print, accepted manuscript ecc. (versione accettata dall'editore)
Dimensione 470.1 kB
Formato Adobe PDF
470.1 kB Adobe PDF   Visualizza/Apri   Richiedi una copia
Pubblicazioni consigliate

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2434/958018
Citazioni
  • ???jsp.display-item.citation.pmc??? 6
  • Scopus 33
  • ???jsp.display-item.citation.isi??? 31
social impact